Design Therapeutics Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $66606.0 on Mar 25 ’24. In the deal valued at $3.74 per share,17,809 shares were bought. As a result of this transaction, Schmid John P. now holds 26,965 shares worth roughly $0.13 million.
Then, Berger Heather A. bought 1,300 shares, generating $4,866 in total proceeds. Upon buying the shares at $3.74, the Director now owns 1,300 shares.
Before that, Schmid John P. bought 9,156 shares. Design Therapeutics Inc shares valued at $33,133 were divested by the Director at a price of $3.62 per share. As a result of the transaction, Schmid John P. now holds 9,156 shares, worth roughly $42941.64000000001.
Piper Sandler upgraded its Design Therapeutics Inc [DSGN] rating to an Overweight from a a Neutral in a research note published on May 07, 2024; the price target was increased to $12 from $6. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in mid November from “an Overweight” to “a Neutral”. Wedbush also remained covering DSGN and has decreased its forecast on August 15, 2023 with a “Neutral” recommendation from previously “an Outperform” rating. SVB Securities revised its rating on August 15, 2023. It rated DSGN as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of DSGN
On Tuesday, Design Therapeutics Inc [NASDAQ:DSGN] saw its stock jump 28.49% to $4.69. Over the last five days, the stock has gained 33.24%. Design Therapeutics Inc shares have risen nearly 76.98% since the year began. Nevertheless, the stocks have fallen -38.13% over the past one year. While a 52-week high of $8.47 was reached on 05/07/24, a 52-week low of $1.94 was recorded on 02/13/24. SMA at 50 days reached $3.42, while 200 days put it at $3.04. A total of 1.78 million shares were traded, compared to the trading of 0.17 million shares in the previous session.
Levels Of Support And Resistance For DSGN Stock
The 24-hour chart illustrates a support level at 4.06, which if violated will result in even more drops to 3.44. On the upside, there is a resistance level at 5.03. A further resistance level may holdings at 5.38. The Relative Strength Index (RSI) on the 14-day chart is 72.20, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 4.84%. Stochastics %K at 50.69% indicates the stock is a holding.
